# Nektar Therapeutics: Form 8-K, filed Mar 28, 2025

- Company: [Nektar Therapeutics](/companies/nktr.md) (CIK 906709)
- Form: 8-K
- Filed: 2025-03-28
- Accepted by EDGAR: Mar 28, 2025, 21:09 ET
- Period: 2025-03-28
- Accession: 0001013762-25-004236
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/906709/000101376225004236/ea0236055-8k_nektar.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/906709/000101376225004236/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/906709/000101376225004236/ea0236055-8k_nektar.htm

Filed Mar 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001013762-25-004236. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.